Safety and Tolerability of Single and Multiple Doses of Neumifil

NCT05093530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Respiratory Tract Infection

Interventions

DRUG: Neumifil
DRUG: Placebo

Sponsor

Pneumagen Ltd.